Skip to content
PubMed This is a summary of 68 peer-reviewed journal articles Updated
Neuro-oncology · Leptomeningeal Metastasis from Melanoma

Leptomeningeal Melanoma: A Patient Guide

At a Glance

Leptomeningeal melanoma occurs when melanoma cells spread into the fluid and membranes around the brain and spinal cord. Diagnosis usually combines contrast MRI of the brain and full spine with cerebrospinal fluid testing, while treatment is individualized.

Leptomeningeal disease (LMD), also known as leptomeningeal metastasis from melanoma, is a serious complication of advanced melanoma. It occurs when cancer cells enter the cerebrospinal fluid (CSF) and the thin, protective layers surrounding the brain and spinal cord known as the leptomeninges [1]. Because the CSF circulates, melanoma cells can travel through the fluid, creating a challenging tumor environment that is biologically distinct from the rest of the body [2].

While this diagnosis was historically associated with a very poor outlook, the introduction of modern therapies has begun to change the landscape of care. The focus has shifted toward individualized treatment strategies that aim to protect the nervous system and manage the patient’s quality of life [3].

What You Should Know Today

If you have just received this diagnosis, here are the core principles to keep in mind:

  1. Comprehensive Diagnostics Are Essential: Accurate management requires looking at the entire central nervous system. Doctors use contrast-enhanced MRI of both the brain and the full spine, alongside detailed analysis of the CSF, to identify where the cancer has settled [4].
  2. Watch for Neurological Symptoms: Melanoma in the fluid can cause multifocal symptoms—issues occurring in different parts of the body simultaneously, such as a severe headache paired with leg weakness or double vision [5]. Call your oncology team promptly for any new neurological changes, and call 911 for severe emergencies like seizures, acute paralysis, or loss of bowel/bladder control.
  3. Treatment is Highly Individualized: There is no single “standard” treatment path. Based on your symptoms, tumor genetics, and overall health, your team may consider systemic dual immunotherapies, targeted BRAF/MEK inhibitors, radiation, or clinical trials [6][7]. Durable control occurs in select patients, though it is not guaranteed.
  4. You Need a Multidisciplinary Team: Because the condition can cause physical complications like hydrocephalus (fluid buildup), a team including neuro-oncologists, neurosurgeons, palliative care specialists, and radiation oncologists is essential to manage both the cancer and the symptoms that impact your daily function [8].

Living with leptomeningeal metastasis involves a careful balance of disease-directed treatment and supportive care. By working closely with a specialized team, you can develop a plan that reflects your personal goals and addresses the unique challenges of this condition [9].

Common questions in this guide

What is leptomeningeal melanoma?
Leptomeningeal melanoma, also called leptomeningeal metastasis from melanoma, occurs when melanoma cells enter the cerebrospinal fluid and the membranes around the brain and spinal cord. Because the fluid circulates, the cancer can affect multiple areas of the nervous system.
What tests are used to diagnose leptomeningeal melanoma?
Doctors generally use contrast-enhanced MRI of the brain and the full spine to look for cancer in the central nervous system. They also analyze cerebrospinal fluid, often called CSF, to look for melanoma cells and other signs of disease.
Which neurological symptoms should I report to my care team?
Report new or worsening symptoms such as severe headache, leg weakness, double vision, vision changes, or unsteadiness promptly to your oncology team. Call 911 for a seizure, sudden paralysis, or loss of bowel or bladder control.
How is leptomeningeal melanoma treated?
There is no single treatment plan for everyone. Depending on symptoms, tumor genetics, and overall health, treatment may include ipilimumab with nivolumab, BRAF/MEK inhibitors, radiation therapy, a clinical trial, and supportive care.
Can leptomeningeal melanoma cause hydrocephalus?
Yes, leptomeningeal melanoma can cause hydrocephalus, which is a buildup of fluid that can affect brain function and cause symptoms. Your multidisciplinary team can monitor for it and discuss a treatment plan if it develops.
Which specialists should be involved in my care?
Care commonly involves a neuro-oncologist and melanoma or medical oncologist, with input from neurosurgery, radiation oncology, and palliative care. These specialists coordinate cancer treatment, symptom management, nervous-system complications, and quality-of-life goals.

Get notified when new evidence is published on leptomeningeal melanoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    [Spinal metastases combined with leptomeningeal metastasis: A case report].

    Ma LJ, Hu PP, Liu XG

    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2023; (55(3)):563-566.

    PMID: 37291936
  2. 2

    Leptomeningeal Disease (LMD) in Patients with Melanoma Metastases.

    Khaled ML, Tarhini AA, Forsyth PA, et al.

    Cancers 2023; (15(6)) doi:10.3390/cancers15061884.

    PMID: 36980770
  3. 3

    Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).

    Ferguson SD, Bindal S, Bassett RL, et al.

    Journal of neuro-oncology 2019; (142(3)):499-509 doi:10.1007/s11060-019-03121-2.

    PMID: 30847840
  4. 4

    Cerebrospinal Fluid Dissemination and Neoplastic Meningitis in Primary Brain Tumors.

    Chowdhary S, Damlo S, Chamberlain MC

    Cancer control : journal of the Moffitt Cancer Center 2017; (24(1)):S1-S16 doi:10.1177/107327481702400118.

    PMID: 28557973
  5. 5

    Pathophysiology and treatment of leptomeningeal metastases in lung cancer.

    Hida T

    Translational lung cancer research 2026; (15(1)):19 doi:10.21037/tlcr-2025-aw-1247.

    PMID: 41659263
  6. 6

    Melanoma brain metastases - Interdisciplinary management recommendations 2020.

    Gutzmer R, Vordermark D, Hassel JC, et al.

    Cancer treatment reviews 2020; (89()):102083 doi:10.1016/j.ctrv.2020.102083.

    PMID: 32736188
  7. 7

    Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.

    Glitza Oliva IC, Ferguson SD, Bassett R, et al.

    Nature medicine 2023; (29(4)):898-905 doi:10.1038/s41591-022-02170-x.

    PMID: 36997799
  8. 8

    Surgical Treatment for Leptomeningeal Disease.

    Volkov AA, Filis AK, Vrionis FD

    Cancer control : journal of the Moffitt Cancer Center 2017; (24(1)):47-53 doi:10.1177/107327481702400107.

    PMID: 28178712
  9. 9

    Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions.

    Wilcox JA, Chukwueke UN, Ahn MJ, et al.

    Neuro-oncology 2024; (26(10)):1781-1804 doi:10.1093/neuonc/noae103.

    PMID: 38902944

This page is for informational purposes only and does not constitute medical advice. Your oncology and neuro-oncology teams should interpret your symptoms and test results and discuss treatment choices for your situation.